Avoro Capital Advisors LLC Vanda Pharmaceuticals Inc. Transaction History

Avoro Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $8.16 Million - $13.5 Million	-430,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $43.3 Million - $54.5 Million	-2,370,191 Reduced 84.64%	430,000 $9.87 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $348,750 - $478,749	25,000 Added 0.9%	2,800,191 $53.3 Million
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $19.2 Million - $27.6 Million	1,366,245 Added 96.97%	2,775,191 $46.8 Million
Q4 2017 Feb 14, 2018	BUY	$12.85 - $18.1 $5.41 Million - $7.61 Million	420,676 Added 42.57%	1,408,946 $21.4 Million
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $15.2 Million - $18.6 Million	988,270	988,270 $17.7 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.